- Home
- JBHT vs NBIX Comparison
JBHT vs NBIX Comparison
Compare JBHT & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JBHT | NBIX |
|---|---|---|
| Founded | 1961 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 14.4B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | JBHT | NBIX |
|---|---|---|
| Price | $188.68 | $155.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 19 |
| Target Price | $168.72 | ★ $173.79 |
| AVG Volume (30 Days) | ★ 1.3M | 969.9K |
| Earning Date | 01-15-2026 | 10-28-2025 |
| Dividend Yield | ★ 0.93% | N/A |
| EPS Growth | 5.00 | ★ 12.44 |
| EPS | ★ 5.77 | 4.19 |
| Revenue | ★ $12,048,818,000.00 | $2,682,700,000.00 |
| Revenue This Year | $1.31 | $23.76 |
| Revenue Next Year | $3.88 | $18.01 |
| P/E Ratio | ★ $32.63 | $37.10 |
| Revenue Growth | N/A | ★ 19.61 |
| 52 Week Low | $122.79 | $84.23 |
| 52 Week High | $190.95 | $157.67 |
Technical Indicators
Market Signals| Indicator | JBHT | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 75.79 | 64.81 |
| Support Level | $172.79 | $150.26 |
| Resistance Level | $190.95 | $154.35 |
| Average True Range (ATR) | 4.91 | 4.16 |
| MACD | 1.91 | 1.07 |
| Stochastic Oscillator | 92.38 | 93.25 |
Price Performance
Historical ComparisonAbout JBHT J.B. Hunt Transport Services Inc.
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (48% of sales), dedicated trucking services that provide customer-specific fleet needs (27%), for-hire truckload (6%), heavy goods final-mile delivery (7%), and asset-light truck brokerage (12%).
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.